share_log

Wells Fargo Maintains Overweight on Zymeworks, Raises Price Target to $14

Moomoo 24/7 ·  Mar 12 07:17

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $12 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment